Retinal nerve fibre layer and macular thinning in spinocerebellar ataxia and cerebellar multisystem atrophy

Neuro-Ophthalmology

Volumn 35, Issue 3, 2011, Pages 108-114

  Pula, John H ^a   Towle, Vernon L ^b   Staszak, Victoria M ^b   Cao, Dingcai ^b   Bernard, Jacqueline T ^b   Gomez, Christopher M ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Ataxia; multisystem atrophy; neuro ophthalmology; trinucleotide repeat diseases

Indexed keywords

ADULT; AGED; ARTICLE; CEREBELLUM ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; PATIENT ASSESSMENT; RETINA MACULA DEGENERATION; RETINA NERVE CELL; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SPINOCEREBELLAR DEGENERATION;

EID: 79959459201     PISSN: 01658107     EISSN: 1744506X     Source Type: Journal    
DOI: 10.3109/01658107.2011.580898     Document Type: Article

References (40)

1. Koeppen AH. The pathogenesis of spinocerebellar ataxia. Cerebellum 2005;4:62-73. (Pubitemid 40592813)
2. Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010;9:885-894.
3. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
4. Buttner N, Geschwind D, Jen JC, Perlman S, Pulst SM, Baloh RW. Oculomotor phenotypes in autosomal dominant ataxias. Arch Neurol 1998;55:1353-1357. (Pubitemid 28465871)
5. Burk K, Fetter M, Abele M, Laccone F, Brice A, Dichgans J, Klockgether T. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol 1999;246:789-797. (Pubitemid 29467154)
6. Globas C, du Montcel ST, Baliko L, Boesch S, Depondt C, DiDonato S, Durr A, Filla A, Klockgether T, Mariotti C, Melegh B, Rakowicz M, Ribai P, Rola R, Schmitz-Hubsch T, Szymanski S, Timmann D, Van de Warrenburg BP, Bauer P, Schols L. Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord 2008;23:2232-2238.
7. Rivaud-Pechoux S, Durr A, Gaymard B, Cancel G, Ploner CJ, Agid Y, Brice A, Pierrot-Deseilligny C. Eye movement abnormalities correlate with genotype in autosomal domi-nant cerebellar ataxia type I. Ann Neurol 1998;43:297-302. (Pubitemid 28113591)
8. Abe T, Abe K, Aoki M, Itoyama Y, Tamai M. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch Ophthalmol 1997;115:231-236. (Pubitemid 27083796)
9. Schols L, Linnemann C, Globas C. Electrophysiology in spi-nocerebellar ataxias: spread of disease and characteristic fnd-ings. Cerebellum 2008;7:198-203.
10. Abele M, Burk K, Andres F, Topka H, Laccone F, Bosch S, Brice A, Cancel G, Dichgans J, Klockgether T. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain 1997;120(Pt 12):2141-2148. (Pubitemid 28014590)
11. Burk K, Abele M, Fetter M, Dichgans J, Skalej M, Laccone F, Didierjean O, Brice A, Klockgether T. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain 1996;119 (Pt 5):1497-1505. (Pubitemid 26375722)
12. Kimura A, Nemoto H, Nishimiya J, Yuasa T, Yamazaki H. Spinocerebellar degeneration with negative electroretino-gram: dysfunction of the bipolar cells. Doc Ophthalmol 2004;108:241-247. (Pubitemid 39433596)
13. Barnes CS, Yan J, Wilmot GR. A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA). Doc Ophthalmol 2009;118:247-256.
14. Babovic-Vuksanovic D, Snow K, Patterson MC, Michels VV. Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion. Am J Med Genet 1998;79:383-387. (Pubitemid 28445450)
15. Rufa A, Dotti MT, Galli L, Orrico A, Sicurelli F, Federico A. Spinocerebellar ataxia type 2 (SCA2) associated with retinal pigmentary degeneration. Eur Neurol 2002;47:128-129. (Pubitemid 34161170)
16. Fukutake T, Kamitsukasa I, Arai K, Hattori T, Nakajima T. A patient homozygous for the SCA6 gene with retinitis pig-mentosa. Clin Genet 2002;61:375-379. (Pubitemid 36372669)
17. Blumenthal EZ, Parikh RS, Pe'er J, Naik M, Kaliner E, Cohen MJ, Prabakaran S, Kogan M, Thomas R. Retinal nerve fbre layer imaging compared with histological measurements in a human eye. Eye (Lond) 2009;23:171-175.
18. Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA. Retinal nerve fber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007;69:1603-1609. (Pubitemid 350287144)
19. Grazioli E, Zivadinov R, Weinstock-Guttman B, Lincoff N, Baier M, Wong JR, Hussein S, Cox JL, Hojnacki D, Ramanathan M. Retinal nerve fber layer thickness is associ-ated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008;268:12-17. (Pubitemid 351389462)
20. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007;69:2085-2092. (Pubitemid 350175711)
21. Zaveri MS, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM. Retinal imag-ing by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol 2008;65:924-928. (Pubitemid 352008476)
22. Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ. Longitudinal study of vision and retinal nerve fber layer thickness in multiple sclerosis. Ann Neurol 2010;67:749-760.
23. Pueyo V, Ara JR, Almarcegui C, Martin J, Guerri N, Garcia E, Pablo LE, Honrubia FM, Fernandez FJ. Sub-clinical atro-phy of the retinal nerve fbre layer in multiple sclerosis. Acta Ophthalmol 2010;88:748-752.
24. Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype. Exp Eye Res 2002;74:737-745. (Pubitemid 34948373)
25. Miller RC, Tewari A, Miller JA, Garbern J, Van Stavern GP. Neuro-ophthalmologic features of spinocerebellar ataxia type 7. J Neuroophthalmol 2009;29:180-186.
26. Abe T, Tsuda T, Yoshida M, Wada Y, Kano T, Itoyama Y, Tamai M. Macular degeneration associated with aberrant expan-sion of trinucleotide repeat of the SCA7 gene in 2 Japanese families. Arch Ophthalmol 2000;118:1415-1421.
27. Manrique RK, Noval S, Aguilar-Amat MJ, Arpa J, Rosa I, Contreras I. Ophthalmic features of spinocerebellar ataxia type 7. J Neuroophthalmol 2009;29:174-179.
28. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Zoghbi HY. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 indi-viduals. Nat Genet 1995;10:94-98.
29. Xu HP, Zhao JW, Yang XL. Cholinergic and dopaminergic amacrine cells differentially express calcium channel sub-units in the rat retina. Neuroscience 2003;118:763-768. (Pubitemid 36506963)
30. Diez-Roux G, Banf S, Sultan M, Geffers L, Anand S, Rozado D, Magen A, Canidio E, Pagani M, Peluso I, Lin-Marq N, Koch M, Bilio M, Cantiello I, Verde R, De Masi C, Bianchi SA, Cicchini J, Perroud E, Mehmeti S, Dagand E, Schrinner S,Nürnberger A, Schmidt K, Metz K, Zwingmann C, Brieske N, Springer C, Hernandez AM, Herzog S, Grabbe F, Sieverding C, Fischer B, Schrader K, Brockmeyer M,Dettmer S, Helbig C, Alunni V Battaini MA, Mura C, Henrichsen CN, Garcia-Lopez R, Echevarria D, Puelles E, Garcia-Calero E, Kruse S, Uhr M, Kauck C, Feng G, Milyaev N, Ong CK Kumar L, Lam M, Semple CA, Gyenesei A, Mundlos S, Radelof U, Lehrach H, Sarmientos P, Reymond A, Davidson DR, Dollé P, Antonarakis SE, Yaspo ML, Martinez S, Baldock RA, Eichele G, Ballabio A. A high-resolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol. 2011 Jan 18;9(1):e1000582. PubMed PMID: 21267068; PubMed Central PMCID: PMC3022534.
31. Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schols L, Szymanski S, van de Warrenburg BP, Durr A, Klockgether T, Fancellu R. Scale for the assess-ment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717-1720. (Pubitemid 43964628)
32. Schmitz-Hubsch T, Fimmers R, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, Linnemann C, Schols L, Timmann D, Filla A, Salvatore E, Infante J, Giunti P, Labrum R, Kremer B, van de Warrenburg BP, Baliko L, Melegh B, Depondt C, Schulz J, du Montcel ST, Klockgether T. Responsiveness of different rating instruments in spinoc-erebellar ataxia patients. Neurology 2010;74:678-684.
33. Kahle JJ, Gulbahce N, Shaw CA, Lim J, Hill DE, Barabasi AL, Zoghbi HY. Comparison of an expanded ataxia inter-actome with patient medical records reveals a relationship between macular degeneration and ataxia. Hum Mol Genet 2011;20:510-527.
34. Kumar N, Pulido JS. High-defnition spectral domain opti-cal coherence tomography in the evaluation of ataxia with visual impairment. Br J Ophthalmol 2010, Br J Ophthalmol. 2011 Apr;95(4):591-598.
35. Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Reproducibility of optical coherence tomogra-phy in multiple sclerosis. Arch Neurol 2008;65:1218-1222.
36. Martinez A, Proupim N, Sanchez M. Retinal nerve fbre layer thickness measurements using optical coherence tomography in migraine patients. Br J Ophthalmol 2008;92:1069-1075.
37. Iseri PK, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006;26:18-24. (Pubitemid 44502755)
38. Altintas O, Iseri P, Ozkan B, Caglar Y. Correlation between ret-inal morphological and functional fndings and clinical sever-ity in Parkinson's disease. Doc Ophthalmol 2008;116:137-146. (Pubitemid 351279805)
39. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. Morphologic changes and functional retinal impairment in patients with Parkinson dis-ease without visual loss. Eur J Ophthalmol 2011;21:24-29.
40. Feuer WJ, Budenz DL, Anderson DR, Cantor L, Greenfeld DS, Savell J, Schuman JS, Varma R. Topographic differences in the age-related changes in the retinal nerve fber layer of normal eyes measured by stratus optical coherence tomog-raphy. J Glaucoma 2011;20:133-138.